Latigo Biotherapeutics, Inc. (LTGO) stock
Close on Nov 12, 2026Market cap $857.25MP/E –Yield 0.00%
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $857.25M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.18
- Dividend yield
- 0.00%
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $10.41
- Diluted shares
- 38M
Trading
- Previous close
- $13.52
- Open
- $13.35
- Day's range
- $12.20 – $13.59
- Volume
- 167,664
- Average volume (20 days)
- 254,875
- RSI (14 days)
- 41.1
- Relative volume
- 0.58×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | LTGO | S&P 500 | Difference | LTGO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -19.3% | -2.7% | −16.6 pts | ||
| 3 months | -33.3% | -1.7% | −31.5 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Latigo Biotherapeutics filed with the SEC as exhibits to Form 8-K or 6-K
Latigo Biotherapeutics stock: common questions
What is Latigo Biotherapeutics's stock price?
LTGO closed at $12.93 on Nov 12, 2026, down 4.36% on the day.
What is Latigo Biotherapeutics's market cap?
Latigo Biotherapeutics was worth $857.25M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
Does Latigo Biotherapeutics pay a dividend?
No. Latigo Biotherapeutics has not paid a cash dividend over the last twelve months.
How many LTGO shares are sold short?
1M shares were sold short at the latest FINRA report, 2.63% of the float, or 5.4 days of average trading volume.
Who are Latigo Biotherapeutics's competitors?
Companies most similar to Latigo Biotherapeutics by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?